Autres langues China Biotech Services Holdings Limited

Actions

8037

BMG2152F1014

Installations et services en soins de santé

Marché Fermé - Hong Kong S.E. 10:08:05 18/08/2026			Varia. 5j.	Varia. 1 janv.
0,6200 ^HKD	-0,80%		0,00%	-21,52%

03/08	China Biotech Services Holdings Limited : Pengbo (Hainan) Medical Technology Co., Ltd. présente les premiers résultats de suivi de la thérapie par capture de neutrons par le bore lors du 22ème Congrès sur la thérapie par capture de neutrons au Japon	CI
18/05	China Biotech Services : sa filiale cède l'intégralité de ses parts dans PHC Medical Diagnostic Centre et d'autres entités	RE

Autres langues

03/08	China Biotech Services Holdings Limited's Japan, Pengbo Medical Technology Co., Ltd. Present of Initial Follow-Up Findings of Boron Neutron Capture Therapy At the 22Nd Congress on Neutron Capture Therapy
18/05	China Biotech Services' unit disposes entire stake in PHC Medical Diagnostic Centre, others
30/04	China Biotech Services says He Xun resigns as executive director
30/04	China Biotech Services Holdings Limited Announces Resignation He Xun as Executive Director, Effective May 1, 2026
29/04	China Biotech Services Holdings Limited Auditor Raises 'Going Concern' Doubt
27/03	China Biotech Services Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2025
06/03	China Biotech Services expects FY net loss of not more than HK$100 million
06/03	China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2025
20/02	China Biotech Services Holdings Limited announced that it has received HKD 272.3 million in funding from Wealth Strategy Holding Ltd
30/12	China Biotech Services to issue convertible bonds
29/12	China Biotech Services Holdings Limited announced that it expects to receive HKD 272.3 million in funding
29/09/25	China Biotech Services says outstanding convertible bonds amount to $6 million
11/09/25	China Biotech Services' unit enters loan contract with Hainan Rural Commercial Bank
27/08/25	China Biotech Services Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2025
08/08/25	China Biotech Services expects loss to be not more than HK$33 million for HY
08/08/25	China Biotech Services Holdings Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2025
25/07/25	China Biotech Services appoints Yin Ye as executive director
25/07/25	China Biotech Services Holdings Limited Announces Board and Committee Changes
11/07/25	China Biotech Services enters MoU for boron neutron capture therapy insurance product
11/07/25	AXA China Region Insurance Company Limited and AXA International Reinsurance Company Limited Enters into Non-Legally Binding Memorandum of Understanding in Relation to the Collaboration on BNCT Medical Insurance Product
15/05/25	China Biotech Services Holdings Limited Announces Change of Company Secretary
08/05/25	China Biotech Services Signs Memorandum Of Understanding With Stella Pharma Corporation
08/05/25	China Biotech Services Holdings Limited, Pengbo Medical Technology Co., Ltd. and Stella Pharma Corporation Enter into Memorandum of Understanding
28/03/25	China Biotech Services Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2024
03/03/25	China Biotech Services Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2024